Fintel reports that on April 4, 2025, Argus Research downgraded their outlook for Biogen (NasdaqGS:BIIB) from Buy to Hold.

Learn more about whether Ionis Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Moderna, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

EQT Foundation is announcing a new global call for proposals under its Breakthrough Science grants program, awarding between ?25,000 to ?100,000 for pioneering researchers tackling women's health ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data were presented at the AD/PD 2025 International Conference on Alzheimer's and Parkinson's Diseases in ...

Dr. Spela Mirosevic signs a historic €1 million funding agreement with the Slovenian government - the first public investment in nonprofit-led gen ...

On Wednesday, 919 stocks advanced, 3115 declined and 109 remained unchanged, with an advance decline ratio of 0.29 on the Bombay Stock Exchange (BSE), indicating negative closing of stocks in broader ...

A food court restaurant called Bourbon Street Grill is getting closer to opening. Approval for its common victualler’s ...

I wrote a story on pediatric private-duty nurses that has become one of our most-read articles so far in 2025 and elicited ...